Target intelligence / Profile preview

Desmosomal proteins in epidermal keratinocytes

Molecular classification
Cell-cell adhesion molecule, Cadherin, Armadillo protein, Plakin, Structural protein
01

Overview

Desmosomal proteins are a group of specialized proteins that form desmosomes, which are intercellular junctions essential for the mechanical strength and integrity of the epidermis. In keratinocytes, these proteins—including desmogleins (DSG1-4), desmocollins (DSC1-3), and plaque proteins like desmoplakin (DSP) and plakoglobin (PG)—link the intermediate filament cytoskeleton of adjacent cells, creating a resilient structural network. They play a critical role in maintaining the skin barrier and are involved in signaling pathways that regulate cell proliferation and differentiation. These proteins are the primary targets in autoimmune blistering diseases such as Pemphigus, where autoantibodies disrupt cell-cell adhesion, leading to acantholysis and blister formation. Additionally, genetic mutations in desmosomal genes result in various skin fragility disorders and keratodermas. Therapeutic interventions primarily aim to suppress the production of pathogenic autoantibodies or selectively eliminate the B cells that target these proteins, with novel approaches like DSG3-CAART cells specifically targeting the B-cell receptors for Desmoglein 3.

Other names
DesmosomeDesmosomal complexMacula adhaerensIntercellular bridgesDesmosomal cadherins
02

Mechanism of action

B-cell depletion, Inhibition of autoantibody production, FcRn inhibition, Selective depletion of Dsg-reactive B cells, Immunosuppression

03

Biological functions

Cell-cell adhesionMechanical integritySignal transductionEpidermal differentiationWound healing
04

Disease associations

Pemphigus vulgarisPemphigus foliaceusParaneoplastic pemphigusPalmoplantar keratodermaSkin fragility syndromeSquamous cell carcinoma
05

Safety considerations

Skin fragilityAcantholysisInfection riskSystemic immunosuppression side effects
06

Interacting drugs

Rituximab

7 more in the full profile.

07

Biomarkers

Anti-Desmoglein 1 antibody titerAnti-Desmoglein 3 antibody titerDirect immunofluorescence (DIF) patternNikolsky sign

Beyond the preview

Go deeper on Desmosomal proteins in epidermal keratinocytes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Desmosomal proteins in epidermal keratinocytes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call